Fact Sheet: Potassium Permanganate INAD 9246

for detailed information, see INAD study protocol, use link on the left
last updated: 1 December 2011

The following links are specific to:
Potassium Permanganate

Drug summary & history

List of FDA-Approved drugs

INAD study protocol

Material Safety Data Sheet

What's the status of this drug's

Print this drug fact sheet

Print all drug fact sheets

Sign-up via the INAD Program Management System (IPMS)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Authorization & Categorical Exclusion Letters

Objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness of potassium permanganate to control external protozoan and metazoan parasites, and bacterial and fungal infections in a variety of warmwater fish species.
Drug name: Potassium permanganate (Cairox)
Source of drug: Carus Chemical Company

315 5th Street
Peru, IL 61354-0599

Contact: Brenda Veronda
Phone: 815-224-6557; Fax: 815-224-6697;
email: brenda.veronda@caruschem.com
webpage: http://www.caruscorporation.com/
Target pathogen(s): external parasites, bacteria, and fungi
Method of administration: Immersion: standing-bath or flow-through treatment
Treatment dosage: 1 - 10 milligrams potassium permanganate per liter
Treatment regimen:

Treatment duration is 1 hour.

Although a single treatment event is generally efficacious, repeated treatments may be used.

Withdrawal period:

7 days

No withdrawal period is required for fish that are not susceptible to legal harvest for a period of 7 days posttreatment.

Required test parameters: Investigator must collect data indicating pretreatment pathogen level, and pathogen level at 1, 4, and 18 hours posttreatment. Investigator should also report general fish behavior and any adverse effects relating to treatment.
Limitations or restrictions on use:

Investigator must follow all instructions in the Study Protocol for INAD 9246 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Drug discharge must be in compliance with local NPDES permitting requirements.

Required INAD fee: none
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242

email: bonnie_johnson@fws.gov
Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.